|
|
Line 3: |
Line 3: |
| <StructureSection load='2h79' size='340' side='right'caption='[[2h79]], [[Resolution|resolution]] 1.87Å' scene=''> | | <StructureSection load='2h79' size='340' side='right'caption='[[2h79]], [[Resolution|resolution]] 1.87Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[2h79]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2H79 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2H79 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2h79]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2H79 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2H79 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=T3:3,5,3TRIIODOTHYRONINE'>T3</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.87Å</td></tr> |
- | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAS:S-(DIMETHYLARSENIC)CYSTEINE'>CAS</scene></td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CAS:S-(DIMETHYLARSENIC)CYSTEINE'>CAS</scene>, <scene name='pdbligand=T3:3,5,3TRIIODOTHYRONINE'>T3</scene></td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2h6w|2h6w]], [[2h77|2h77]]</div></td></tr>
| + | |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">THRA ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
| + | |
| <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2h79 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2h79 OCA], [https://pdbe.org/2h79 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2h79 RCSB], [https://www.ebi.ac.uk/pdbsum/2h79 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2h79 ProSAT]</span></td></tr> | | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2h79 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2h79 OCA], [https://pdbe.org/2h79 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2h79 RCSB], [https://www.ebi.ac.uk/pdbsum/2h79 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2h79 ProSAT]</span></td></tr> |
| </table> | | </table> |
| + | == Disease == |
| + | [https://www.uniprot.org/uniprot/THA_HUMAN THA_HUMAN] Defects in THRA are the cause of congenital hypothyroidism non-goitrous type 6 (CHNG6) [MIM:[https://omim.org/entry/614450 614450]. A disease characterized by growth retardation, developmental retardation, skeletal dysplasia, borderline low thyroxine levels and high triiodothyronine levels. There is differential sensitivity to thyroid hormone action, with retention of hormone responsiveness in the hypothalamic pituitary axis and liver but skeletal, gastrointestinal, and myocardial resistance.<ref>PMID:22168587</ref> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/THA_HUMAN THA_HUMAN] Nuclear hormone receptor. High affinity receptor for triiodothyronine. |
| == Evolutionary Conservation == | | == Evolutionary Conservation == |
| [[Image:Consurf_key_small.gif|200px|right]] | | [[Image:Consurf_key_small.gif|200px|right]] |
Line 36: |
Line 38: |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Ambrosio, A L.B]] | + | [[Category: Ambrosio ALB]] |
- | [[Category: Aparicio, R]] | + | [[Category: Aparicio R]] |
- | [[Category: Baxter, J D]] | + | [[Category: Baxter JD]] |
- | [[Category: Bleicher, L]] | + | [[Category: Bleicher L]] |
- | [[Category: Craievich, A F]] | + | [[Category: Craievich AF]] |
- | [[Category: Dias, S M.G]] | + | [[Category: Dias SMG]] |
- | [[Category: Figueira, A C.M]] | + | [[Category: Figueira ACM]] |
- | [[Category: Fischer, H]] | + | [[Category: Fischer H]] |
- | [[Category: Garrat, R C]] | + | [[Category: Garrat RC]] |
- | [[Category: Nascimento, A S]] | + | [[Category: Nascimento AS]] |
- | [[Category: Neto, M O]] | + | [[Category: Neto MO]] |
- | [[Category: Nunes, F M]] | + | [[Category: Nunes FM]] |
- | [[Category: Polikarpov, I]] | + | [[Category: Polikarpov I]] |
- | [[Category: Santos, M A.M]] | + | [[Category: Santos MAM]] |
- | [[Category: Togashi, H F.M]] | + | [[Category: Togashi HFM]] |
- | [[Category: Webb, P]] | + | [[Category: Webb P]] |
- | [[Category: Hormone-growth factor complex]]
| + | |
- | [[Category: T3]]
| + | |
- | [[Category: Tr]]
| + | |
- | [[Category: Tr alpha]]
| + | |
| Structural highlights
Disease
THA_HUMAN Defects in THRA are the cause of congenital hypothyroidism non-goitrous type 6 (CHNG6) [MIM:614450. A disease characterized by growth retardation, developmental retardation, skeletal dysplasia, borderline low thyroxine levels and high triiodothyronine levels. There is differential sensitivity to thyroid hormone action, with retention of hormone responsiveness in the hypothalamic pituitary axis and liver but skeletal, gastrointestinal, and myocardial resistance.[1]
Function
THA_HUMAN Nuclear hormone receptor. High affinity receptor for triiodothyronine.
Evolutionary Conservation
Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.
Publication Abstract from PubMed
The thyroid hormone receptor (TR) D-domain links the ligand-binding domain (LBD, EF-domain) to the DNA-binding domain (DBD, C-domain), but its structure, and even its existence as a functional unit, are controversial. The D domain is poorly conserved throughout the nuclear receptor family and was originally proposed to comprise an unfolded hinge that facilitates rotation between the LBD and the DBD. Previous TR LBD structures, however, have indicated that the true unstructured region is three to six amino acid residues long and that the D-domain N terminus folds into a short amphipathic alpha-helix (H0) contiguous with the DBD and that the C terminus of the D-domain comprises H1 and H2 of the LBD. Here, we solve structures of TR-LBDs in different crystal forms and show that the N terminus of the TRalpha D-domain can adopt two structures; it can either fold into an amphipathic helix that resembles TRbeta H0 or form an unstructured loop. H0 formation requires contacts with the AF-2 coactivator-binding groove of the neighboring TR LBD, which binds H0 sequences that resemble coactivator LXXLL motifs. Structural analysis of a liganded TR LBD with small angle X-ray scattering (SAXS) suggests that AF-2/H0 interactions mediate dimerization of this protein in solution. We propose that the TR D-domain has the potential to form functionally important extensions of the DBD and LBD or unfold to permit TRs to adapt to different DNA response elements. We also show that mutations of the D domain LXXLL-like motif indeed selectively inhibit TR interactions with an inverted palindromic response element (F2) in vitro and TR activity at this response element in cell-based transfection experiments.
Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.,Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Neto M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov I J Mol Biol. 2006 Jul 14;360(3):586-98. Epub 2006 May 19. PMID:16781732[2]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M, Downes K, Offiah A, Albanese A, Halsall D, Schwabe JW, Bain M, Lindley K, Muntoni F, Vargha-Khadem F, Dattani M, Farooqi IS, Gurnell M, Chatterjee K. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med. 2012 Jan 19;366(3):243-9. doi: 10.1056/NEJMoa1110296. Epub 2011 Dec, 14. PMID:22168587 doi:10.1056/NEJMoa1110296
- ↑ Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Neto M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov I. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J Mol Biol. 2006 Jul 14;360(3):586-98. Epub 2006 May 19. PMID:16781732 doi:http://dx.doi.org/10.1016/j.jmb.2006.05.008
|